New York, New York--(Newsfile Corp. - August 4, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Primoris Services Corporation ("Primoris" or the "Company") (NYSE: PRIM) on behalf of investors that purchased or otherwise acquired Primoris common stock between August 5, 2025 and June 22, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Primoris and have suffered losses, you may CLICK HERE to contact us. You may also...
Sanjay Krishnamurthi joins as Chief Development Officer to lead product innovation and engineering, advancing Maia, Matillion's AI Data Automation platform MANCHESTER, England and SAN FRANCISCO, Aug. 4, 2026 /PRNewswire/ -- Matillion, the AI Data Automation company, today announced the...
NEW YORK, Aug. 4, 2026 /PRNewswire/ -- MMC, an Omnicom Public Relations agency, today introduced a new methodology for understanding culture, designed to identify emerging shifts before they become conventional wisdom and translate them into strategic communications insight. The...
Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines indicated Phase 1 trial is being conducted in Canada as part of our expanded collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI), building on Moderna's prior filovirus research
L'essai de phase 1 évaluera l'innocuité et la réponse immunitaire pour une souche de la maladie à virus Ebola pour laquelle aucun vaccin n'est actuellement autorisé L'essai de phase 1 est mené au Canada dans le cadre de notre collaboration élargie avec la Coalition pour les innovations en matière de préparation aux épidémies (CEPI), s'appuyant sur les recherches antérieures de Moderna sur les filovirus
Unified exposure management leader recognized as a Top InfoSec Innovator and one of the Top 25 Most Innovative Cybersecurity Companies in the World. Visit Nucleus Security in the Black Hat USA Business Hall, Booth #5533 LAS VEGAS, Aug. 4, 2026 /PRNewswire/ -- Nucleus Security, the leader...
Designed around the belief that reducing size should never mean reducing capability, the Epomaker TH65 keyboard brings a complete everyday experience to the 65% layout.
Celebrating Excellence within our Portfolio of Craft Lodging Properties KANSAS CITY, Mo., Aug. 4, 2026 /PRNewswire/ -- Select Registry is proud to announce the finalists for the 2026 Craft Lodging Awards, recognizing outstanding achievements across our collection of exceptional Craft...
Parsippany, New Jersey--(Newsfile Corp. - August 4, 2026) - As SESI Consulting Engineers ("SESI") marks its 50th anniversary, the firm is addressing a fundamental shift that is reshaping real estate development across the Northeast: engineering feasibility is increasingly determining whether projects move forward long before design or approvals begin.Rising construction costs, evolving environmental regulations, infrastructure limitations, and extended municipal review timelines are driving...
Historic ocean-view accommodations to be reimagined with timeless elegance, refined finishes, and thoughtfully curated interiors inspired by the natural beauty of The Bahamas PARADISE ISLAND, Bahamas, Aug. 4, 2026 /PRNewswire/ -- The Ocean Club, A Four Seasons Resort, Bahamas, is pleased...
(PR-inside.com) Strategic Financing to Accelerate Exosome Pipeline Expansion, International Joint Ventures, and Scale-Up of NexTel Medical (MAJI) ORLANDO, FL / ACCESS Newswire / August 4, 2026 / Exousia Bio, Inc. f/k/a LAMY (OTCPINK:LMMY) ("Exo Bio" or the "Company"), a pioneering U.S. biotechnology firm advancing next-generation exosome-based cancer therapeutics, today announced it is finalizing a significant mid-seven-figure investment designed to catalyze its next operational growth phase. The incoming capital will directly fund pivotal growth initiatives, including: Facility Infrastructure: Upgrading and relocating primary laboratory operations to a state-of-the-art Level 2 facility. Global Strategic Partnerships: Expanding international joint venture opportunities in collaboration wit